Hikma Beats Amarin's 'Skinny Label' Patent Suit
Hikma Pharmaceuticals USA Inc.'s generic heart drug does not infringe three patents underlying Amarin Pharma Inc.'s drug Vascepa, a Delaware federal judge ruled Tuesday, breaking with the recommendation from a magistrate...To view the full article, register now.
Already a subscriber? Click here to view full article